PlainRecalls
FDA Drug Low Class III Terminated

Bracco Diagnostics multihance (gadobenate dimeglumine) injection, 529 mg/mL, 20ml, Rx only, Manufactured for: Bracco Diagnostics Inc., Princeton, NJ 08543 USA, NDC 0270-5164-15

Reported: September 5, 2012 Initiated: April 16, 2012 #D-1663-2012

Product Description

Bracco Diagnostics multihance (gadobenate dimeglumine) injection, 529 mg/mL, 20ml, Rx only, Manufactured for: Bracco Diagnostics Inc., Princeton, NJ 08543 USA, NDC 0270-5164-15

Reason for Recall

Short Fill: The product is being recalled due to a potential underfill of the affected vials.

Details

Recalling Firm
Bracco Diagnostics Inc
Units Affected
47,750 vials
Distribution
Nationwide
Location
Monroe Township, NJ

Frequently Asked Questions

What product was recalled?
Bracco Diagnostics multihance (gadobenate dimeglumine) injection, 529 mg/mL, 20ml, Rx only, Manufactured for: Bracco Diagnostics Inc., Princeton, NJ 08543 USA, NDC 0270-5164-15. Recalled by Bracco Diagnostics Inc. Units affected: 47,750 vials.
Why was this product recalled?
Short Fill: The product is being recalled due to a potential underfill of the affected vials.
Which agency issued this recall?
This recall was issued by the FDA Drug on September 5, 2012. Severity: Low. Recall number: D-1663-2012.